Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alimera Sciences Inc (NASDAQ:ALIM)

2.91
Delayed Data
As of Sep 04
 -0.10 / -3.32%
Today’s Change
2.73
Today|||52-Week Range
6.48
-47.47%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close3.01
Today’s open2.99
Day’s range2.82 - 3.02
Volume188,079
Average volume (3 months)99,114
Market cap$133.7M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+43.83%
Earnings growth (this year)+5.86%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+349.95%
P/E ratioNM
Price/Sales26.57
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc+0.02+0.29%
TNXPTonix Pharmaceutical...0.000.00%
EPIXESSA Pharma Inc0.000.00%
VVUSVIVUS Inc-0.07-5.56%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$8.4M
Annual profit (last year)-$36.7M
Net profit margin-435.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts

Partner Offers